Western Asset Municipal Partners Fund Inc. (MNP) At $14.12 Forms Bottom; Can-fite Biopharma Ltd Sponsored Adr (israel) (NYSEAMERICAN:CANF) Shorts Down By 15.21%

Can-fite Biopharma Ltd Sponsored Adr (israel) (NYSEAMERICAN:CANF) had a decrease of 15.21% in short interest. CANF’s SI was 129,900 shares in July as released by FINRA. Its down 15.21% from 153,200 shares previously. With 65,400 avg volume, 2 days are for Can-fite Biopharma Ltd Sponsored Adr (israel) (NYSEAMERICAN:CANF)’s short sellers to cover CANF’s short positions. The SI to Can-fite Biopharma Ltd Sponsored Adr (israel)’s float is 0.81%. The stock increased 1.72% or $0.0199 during the last trading session, reaching $1.1799. About 133,772 shares traded. Can-Fite BioPharma Ltd. (NYSEAMERICAN:CANF) has declined 27.53% since July 1, 2017 and is downtrending. It has underperformed by 40.10% the S&P500. Some Historical CANF News: 09/03/2018 – CAN-FITE BIOPHARMA ANNOUNCES $5 MILLION REGISTERED DIRECT OFFERING; 09/03/2018 – CAN FITE BIOPHARMA LTD – ENTERED INTO DEFINITIVE AGREEMENTS WITH INSTITUTIONAL INVESTORS TO RECEIVE GROSS PROCEEDS OF APPROXIMATELY $5 MLN; 06/03/2018 Can-Fite to Participate in Panel Discussions on Latest Drug Developments in NASH at the 30th Annual ROTH Conference; 09/04/2018 – Can-Fite to Present the Anti-Inflammatory and Anti-Fibrogenic Effects of Namodenoson in NAFLD/NASH Pre-clinical Studies at the; 23/03/2018 – Can-Fite Reports 2017 Financial Results & Provides Clinical Update; 23/03/2018 – CAN FITE BIOPHARMA LTD – AS OF DEC 31, 2017, CAN-FITE HAD CASH AND CASH EQUIVALENTS OF NIS 12.1 MLN VS NIS 31.2 MLN AT DECEMBER 31, 2016; 09/04/2018 – Can-Fite to Present the Anti-lnflammatory and Anti-Fibrogenic Effects of Namodenoson in NAFLD/NASH Pre-clinical Studies at the 2018 International Liver Congress of the European Association for the Study of the Liver (EASL); 09/03/2018 – CAN-FITE BIOPHARMA REPORTS $5M REGISTERED DIRECT OFFERING; 09/03/2018 – CAN FITE BIOPHARMA LTD – WILL ISSUE 3.3 MLN REGISTERED ADSS OF CAN-FITE AT A PURCHASE PRICE OF $1.50 PER ADS IN A REGISTERED DIRECT OFFERING

Western Asset Municipal Partners Fund Inc. (MNP) formed multiple bottom with $12.85 target or 9.00% below today’s $14.12 share price. Western Asset Municipal Partners Fund Inc. (MNP) has $137.23 million valuation. The stock decreased 0.07% or $0.01 during the last trading session, reaching $14.12. About 17,359 shares traded. Western Asset Municipal Partners Fund Inc. (NYSE:MNP) has declined 9.90% since July 1, 2017 and is downtrending. It has underperformed by 22.47% the S&P500.

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and liver diseases, as well as sexual dysfunction. The company has market cap of $25.10 million. The company's lead drug candidate is CF101, which is in Phase III clinical trials for the treatment of rheumatoid arthritis and psoriasis. It currently has negative earnings. It also develops CF102 that is in Phase II clinical trials for the treatment of liver cancer and non-alcoholic fatty liver diseases, as well as for hepatocellular carcinoma and hepatitis C virus diseases; and CF602, which is in pre-clinical trial for the treatment of sexual dysfunction.

Investors sentiment decreased to 1.36 in 2018 Q1. Its down 0.08, from 1.44 in 2017Q4. It fall, as 4 investors sold Western Asset Municipal Partners Fund Inc. shares while 7 reduced holdings. 5 funds opened positions while 10 raised stakes. 1.45 million shares or 12.43% more from 1.29 million shares in 2017Q4 were reported. Royal Bancorp Of Canada reported 39,676 shares stake. Pnc Financial Service Gru has invested 0% in Western Asset Municipal Partners Fund Inc. (NYSE:MNP). Cohen And Steers has invested 0% in Western Asset Municipal Partners Fund Inc. (NYSE:MNP). New Hampshire-based Charter has invested 0.03% in Western Asset Municipal Partners Fund Inc. (NYSE:MNP). Landscape Capital Mngmt Lc owns 20,403 shares. The Minnesota-based Ameriprise Fincl has invested 0% in Western Asset Municipal Partners Fund Inc. (NYSE:MNP). Moreover, Wells Fargo Mn has 0% invested in Western Asset Municipal Partners Fund Inc. (NYSE:MNP) for 29,716 shares. Guggenheim Limited Com reported 0% in Western Asset Municipal Partners Fund Inc. (NYSE:MNP). Morgan Stanley stated it has 74,286 shares or 0% of all its holdings. Wolverine Asset Mgmt Limited Liability Co invested 0.01% of its portfolio in Western Asset Municipal Partners Fund Inc. (NYSE:MNP). Moreover, Raymond James Assocs has 0.01% invested in Western Asset Municipal Partners Fund Inc. (NYSE:MNP) for 244,314 shares. Illinois-based First Tru Advisors Limited Partnership has invested 0% in Western Asset Municipal Partners Fund Inc. (NYSE:MNP). Rmb Capital Management Ltd Liability Corporation invested in 0.01% or 25,034 shares. Sit Invest Associates reported 0.01% of its portfolio in Western Asset Municipal Partners Fund Inc. (NYSE:MNP). Stratos Wealth reported 0% in Western Asset Municipal Partners Fund Inc. (NYSE:MNP).